Lipoprotein(a) [Lp(a)]


Request package insert information

Product Features
Diazyme's Lp(a) is a dual liquid stable reagent system which provides reliable results and is offered with time saving instrument specific packaging options which eliminate reagent transfer and increase operator efficiency. Instrument specific packaging options including RocheTM Hitachi 917 series, Beckman AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The method requires only 6 μl of serum sample completed in less than 10 minutes and has excellent correlation with existing commercial products with r2 of 0.998, slope of 0.99, and y intercept of 0.03. The assay has intra precision values of less than 2.6%.
Assay Principle
Diazyme's Lp(a) Assay is based on a latex enhanced immunoturbidimetric method. Lp(a) in the sample binds to the specific anti-Lp(a) antibody, which is coated on latex particles, and causes agglutination. The degree of the turbidity caused by agglutination can be measured optically and is proportional to the amount of Lp(a) in the sample.
Intended use
The Diazyme Lp(a) is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of lipoprotein(a) [Lp(a)] concentration in human serum or plasma (EDTA) on clinical chemistry systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders and assessing atherosclerotic cardiovascular diseases in specific populations, when used in conjunction with clinical evaluation. For in vitro diagnostic use only.
Product Catalog Number Packaging Method/Format
Kit (300 Tests) DZ131A-K R1: 1 x 60 mL
R2: 1 x 20 mL
Latex Enhanced
Immunoturbidimetric Assay
Liquid Stable
Calibrator DZ131A-Cal 5 x 1 mL  
Control DZ131A-Con 2 x 1 mL  
Control DZ138A-Con 3 x 3 mL  
Alternative Calibrator DZ131B-Cal 5 x 1 mL  
Alternative Control DZ131B-Con 2 x 1 mL